Pfizer Inc. (NYSE:PFE) is one of the stocks in Jim Cramer’s spotlight. A caller asked what Cramer thinks of the company, and in response, he said: “Okay, well, I have not been recommending, my ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine was viable.

Welcome to this week's Chutes & Ladders, our roundup | Sally Susman, the communications chief who has shepherded Pfizer’s reputation and branding for more than 18 years, is departing the pharma ...

Departures: Top Pfizer communications executive Sally Susman is stepping down, effective at the end of the year. Linda Yaccarino resigned as CEO of X. Miscellaneous: Six major medical groups, and a ...

Gwendolyn Fisher, VP of Communications, global digital and technology, GSK “Sally Susman, I can’t believe it has been 18 years! Although our paths overlapped only a short time when I worked at Pfizer, ...

Pfizer (PFE) stock in focus as Sally Susman, the company's Chief Corporate Affairs Officer, plans to depart after 18 years. Read more here.

Sally Susman, who has presided over Pfizer Inc.’s public communications for nearly two decades, will leave the company this year as part of a broader corporate restructuring.

Pfizer’s longtime corporate affairs chief, Sally Susman, will depart this year, the pharmaceutical giant announced Tuesday. Five executives will take on her work, CEO Albert Bourla explained, as ...

NEW YORK: Top Pfizer communications executive Sally Susman is stepping down, effective at the end of the year. The company does not plan to replace Susman as EVP and chief corporate affairs officer.

Explore daily insights on the USA TODAY crossword puzzle by Sally Hoelscher. Uncover expert takes and answers in our crossword blog.

Pfizer PFE faces patent expirations amounting to more than one quarter of 2024 revenue by 2028, and the 2023 acquisition of oncology-focused biotech Seagen boosted the firm’s invested capital ...